Summary
Operating margin recovered to 2.8% from -1.9% in FY2023 as contract labour costs fell [1, p. 14]. Liquidity is solid at 212 days cash on hand, well above the 75-day covenant [1, p. 31]. Leverage is edging down ahead of a planned capital programme.
| Financials | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating Margin | 3.1% | 0.4% | -1.9% | 1.2% | 2.8% |
| Days Cash on Hand | 238 | 221 | 196 | 204 | 212 |
| Debt Service Coverage | 3.4x | 2.6x | 1.7x | 2.3x | 2.9x |
| Debt to Capitalisation | 38% | 41% | 44% | 42% | 40% |
| Operating profile | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Licensed Beds | 412 | 412 | 436 |
| Admissions | 18,940 | 19,615 | 20,380 |
| Occupancy | 68% | 71% | 73% |
| Medicare and Medicaid | 54% | 55% | 57% |
| Labour | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Contract Labour Expense | $44.1M | $38.6M | $17.2M |
| Nurse Vacancy Rate | 14.2% | 10.8% | 7.9% |
Contract labour fell by more than half in FY2025 as a nurse residency programme filled 140 permanent posts [1, p. 15]. Vacancy is now below the 10% state average.
Management and strategy
A new CFO joined in 2024 from a larger Texas system. Strategy centres on outpatient growth in the western suburbs and a patient tower to relieve occupancy at the main campus [2, p. 8].
Risks
- • Medicaid supplemental payments are 9% of revenue, up for renewal in 2027 [1, p. 52]
- • Two competitors are opening free-standing ERs within its service area in 2026 [2, p. 11]
- • Board approved a $140M patient tower, to be funded with new bonds in 2027 [3, p. 3] Added today
References (3)